The AKT inhibitor Capivasertib (AZD5363): from discovery to clinical proof of concept

Add to your list(s) Download to your calendar using vCal

• Dr Barry Davies, Global Project Leader, Oncology Combinations, Early Oncology, AstraZeneca.
• Thursday 03 February 2022, 09:30-10:30
• William Harvey Lecture Theatre, School of Clinical Medicine.

If you have a question about this talk, please contact Justin Holt.

This talk has been canceled/deleted

Abstract not available

This talk is part of the Cancer Research UK Cambridge Centre Lectures in Cancer Biology and Medicine series.

This talk is included in these lists:

This talk is not included in any other list

Note that ex-directory lists are not shown.